Insider Stock Trader

Insider sale LGND

Ligand Pharmaceuticals Inc director Martine Zimmermann sells $636,336 in stock

2,000 shares sold on the open market on Nov 12, at about $318.17 each.

Martine Zimmermann, a director of Ligand Pharmaceuticals Inc (LGND), sold 2,000 shares on Nov 12 at an average price of $318.17, a total of about $640,000, according to a Form 4 filed with the SEC on Nov 16.

The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. It is the eighth insider sale at Ligand Pharmaceuticals Inc reported in the last 90 days.

The filing came 4 days after the trade. After the trade, the filing lists 1,782 shares held.

Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.

The sale
CompanyLigand Pharmaceuticals Inc (LGND)
InsiderMartine Zimmermann
RoleDirector
TransactionOpen-market sale (code S)
Shares2,000
Average price$318.17
Value$636,336
Trade dateNov 12, 2026
Filed with the SECNov 16, 2026, 4:16 PM ET
Shares held after1,782
OwnershipDirect
Rule 10b5-1 planNot marked in the filing

See this filing row by row in Insider Stock Trader

View the Form 4 on SEC.gov

See earlier insider stories on Ligand Pharmaceuticals Inc · Follow LGND for the next insider trade

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.